yabao pharmaceutical group-a
(600351:Shanghai Stock Exchange)
Transactions by YABAO PHARMACEUTICAL GROUP-A (600351) in the last 6 months
Yuncheng Yellow River Golden Triangle First Hospital Co., Ltd. announced that it will receive CNY 900 million in equity funding on August 13, 2015. The transaction will involve participation from new investor, Yabao Pharmaceutical Group Co., Ltd for CNY 800 million and existing investor, Chen Junke for CNY 100 million. Upon closing of the transaction, the registered capital of the company will become CNY 1 billion. Chen Junke will own 15% stake and Yabao Pharmaceutical ...
Yabao Pharmaceutical Group Co., Ltd (SHSE:600351), Guizhou Zipao Yudai Fanjingchan Tea Industry Co., Ltd. and Tan Huili signed a share transfer agreement to acquire Guizhou Xierkang Pharmaceutical Co., Ltd. from Sun Ting and Wang Jianmin on May 15, 2015. Under the terms of the deal, Sun Ting will transfer 69% stake in Guizhou Xierkang Pharmaceutical to Yabao Pharmaceutical Group at zero cost, Sun Ting will transfer 20% stake in Guizhou Xierkang Pharmaceutical to Guizhou ...
Yabao Pharmaceutical Group Co., Ltd
|No competitor information is available for 600351.|
|View Industry Companies|